# Scopia — Full Site Content for AI Systems > Colonoscopy quality monitoring SaaS for endoscopy units. ESGE-compliant, nurse-led workflow. No EHR integration required. EU-hosted, GDPR compliant. Scopia is a cloud-based quality monitoring platform purpose-built for colonoscopy and endoscopy units. It enables nurse-led quality data logging in under 60 seconds per procedure, automatic endoscopist feedback, anonymous benchmarking against ESGE targets and peer units, and chief physician dashboards with real-time oversight. - Website: https://scopia.app - Contact: info@scopia.app - Company: Scopia Oy, Espoo, Finland - Founded: 2024 - Languages: English, Finnish (/fi/), Swedish (/sv/), German (/de/) --- ## Homepage URL: https://scopia.app/ ### Colonoscopy Quality Monitoring Without the Extra Work ESGE-compliant colonoscopy quality monitoring for endoscopy units. Track ADR, CIR, and more. Works without EHR integration. Start in days. "Measuring and improving colonoscopy quality saves lives. Scopia makes that achievable for every endoscopy unit." — Mika Puhto, MD, Chief Physician, Gastroenterology, South Savo Hospital District ### Built for Your Entire Endoscopy Unit **Chief Physicians:** Unit-level dashboards, ESGE benchmarking, and endoscopist comparisons. Ready-made evidence for quality meetings and accreditation. **Endoscopy Nurses:** Fast, intuitive quality logging during or after procedures. Under 60 seconds per colonoscopy. Works on any device. **Hospital IT:** No EHR integration required. Cloud-based, GDPR compliant, EU-hosted. Up and running in days with zero IT resources. ### AI Impact Analytics Independently measure whether your CADe system actually improves adenoma detection — AI-on vs. AI-off comparison per endoscopist. Vendor-neutral. Works with GI Genius, CAD EYE, ENDO-AID, and others. ### Research Collaboration Use Scopia as your multi-center research infrastructure. Standardized, ESGE-compliant data collection across sites — start collecting in days, not months. - Identical structured forms across all centers - Real-time multi-center data dashboard - Publication-ready data — no months of cleaning Research License includes: Full Scopia access for all participating sites, benchmarking data against anonymized international data, and up to 50% reduced academic pricing. --- ## Product URL: https://scopia.app/product ### Daily Quality Tool for Every Endoscopy Unit Track ESGE-compliant quality indicators, get automated endoscopist feedback, and benchmark your unit — all powered by a 60-second nurse-led workflow. ### What Scopia Does **Nurse-Led Logging:** Nurses log quality metrics in under 60 seconds per procedure — no endoscopist time required. Data collection fits naturally into the existing workflow. **Automatic Feedback:** Every endoscopist receives personal, anonymised feedback on their key quality indicators. No manual reporting needed. **Anonymous Benchmarking:** Compare your unit's performance against ESGE targets and peer units. See where you stand without revealing individual identities. **Chief Physician Dashboard:** Unit-level overview of all quality indicators, trends over time, and endoscopist-level comparisons. Automated summary reports sent to leadership at regular intervals — no extra work needed. Ready-made evidence for quality meetings and accreditation. **ESGE-Compliant Metrics:** Track all recommended indicators: ADR, CIR, withdrawal time, bowel preparation quality, patient comfort, and more — aligned with European guidelines. **Device-Agnostic:** Works on any device with a browser — tablets, phones, desktops. No app installation needed. Use the devices already in your endoscopy unit. ### Quality Monitoring Without the Bottleneck **Endoscopy Nurse:** Logs procedure quality in under 60 seconds during the natural workflow. Simple, intuitive interface designed for the endoscopy room. **Endoscopist:** Receives automatic, personal feedback on key quality metrics. No data entry, no extra work — just continuous improvement insights. **Chief Physician:** Gets a real-time dashboard with unit-level metrics, trends, and benchmarking. Ready-made evidence for quality reviews and accreditation. ### Works Standalone — or Integrated Scopia works out of the box without any hospital IT integration. When you're ready, we offer EHR and endoscopy system integrations tailored to your needs. What you won't need to start: - Lengthy procurement processes - Server installations - Maintenance burden on hospital IT - Mandatory EHR integration before go-live From sign-up to first data: Under 1 week. --- ## The Science Behind Colonoscopy Quality URL: https://scopia.app/science Scopia is built on decades of research showing that measuring quality indicators and providing feedback directly improves patient outcomes. Medically reviewed by: Mika Puhto, MD, Chief Physician, Gastroenterology ### Quality Indicators Explained **Adenoma Detection Rate (ADR):** Percentage of screening colonoscopies with at least one adenoma detected. The single most important quality indicator for colonoscopy. **Cecal Intubation Rate (CIR):** Percentage of procedures reaching the cecum. Indicates completeness of the examination. **Withdrawal Time:** Time from cecum to rectosigmoid in minutes. Minimum 6 minutes required for adequate inspection of the colonic mucosa. **Bowel Preparation Quality:** Percentage of procedures with adequate or excellent preparation. Poor preparation leads to missed lesions. **Patient Comfort:** Pain and discomfort scores during and after procedures. ### ESGE Quality Targets - ADR: ≥25% (screening), ≥30% (surveillance) - CIR: ≥95% - Withdrawal Time: ≥6 minutes (minimum) - Bowel Preparation: ≥90% adequate or better ### Key Research Finding: Every 1% ADR Increase = 3% Fewer Interval Cancers Research published in the New England Journal of Medicine (Corley et al., 2014) demonstrates a direct link between adenoma detection rate and interval colorectal cancer risk. Improving ADR saves lives. ### Audit and Feedback Measurement combined with feedback and accountability drives quality improvement in medical practice. Audit and feedback interventions improve ADR by an average of 7 percentage points. ### Quality Monitoring Impact Systematic quality monitoring leads to: - Behavior change in endoscopists - Improved technique adoption - Training focus on weak areas - Equipment improvements - Reduced variation between clinicians --- ## Proven Results URL: https://scopia.app/results ### Quality Results vs ESGE Targets | Indicator | Scopia Result | ESGE Target | |-----------|--------------|-------------| | ADR | 53.0% | ≥25% | | CIR | 96.5% | ≥95% | | Withdrawal Time | 11.4 min | ≥6 min | | Prep Quality | 96.9% | ≥90% | ### Case Study: South Savo Hospital District **Finnish Medical Association Quality Award 2025** South Savo was already tracking colonoscopy quality in Excel, but the manual process was time-consuming for the chief physician. Endoscopists received no automated feedback on their own performance, and turning spreadsheet data into actionable improvements was laborious. Scopia replaced the spreadsheet with nurse-led quality logging. The chief physician's manual work was eliminated, endoscopists began receiving automated personal feedback, and all ESGE indicators became available in a real-time dashboard. Results: - ADR increased by 20 percentage points (from 33% baseline to 53%) - ADR reached 53% — ESGE minimum is 25%, exceeded by 28 percentage points - Patient comfort improved significantly "Scopia helped us uncover quality gaps we didn't know existed. The data-driven approach has transformed how our entire unit works." — Gastroenterologist, Scopia pilot unit ### Case Study: Mehiläinen — Finland's Largest Private Healthcare Network Finland's largest private healthcare provider chose Scopia after a rigorous pilot: 1,000 colonoscopies tracked across 17 endoscopes. The results led to a decision to roll out network-wide. Network Stats: - 15+ endoscopy units - 50+ endoscopists and nurses - Hundreds of quality reports per month - Built on Scopia API with PowerBI reporting Timeline: - 2024: Pilot — 1,000 colonoscopies, 17 endoscopes - 2025: Network-wide rollout to 15+ units - 2026: Hundreds of quality reports per month — and growing "Based on pilot results, colonoscopy quality in our high-volume units is excellent. We gained valuable insights into screening coverage and patient experience. Through data, we will continue to elevate quality further." — Fredrik Forsström, MD, National Chief Gastroenterologist, Mehiläinen --- ## AI Impact Analytics URL: https://scopia.app/ai-impact ### Measure Whether Your AI Investment Actually Works You've invested €100,000+ in AI-assisted polyp detection. But do you know if it's actually improving your unit's quality? ### The Problem: €100K+ Invested in CADe — But No Independent Measurement Critical questions without answers: - Does ADR actually improve with AI on? - Does each endoscopist benefit equally? - What happens when AI is turned off? - Is there a deskilling risk? ### The Deskilling Problem A 2025 Lancet Gastroenterology & Hepatology study found that endoscopists' ADR dropped by 6 percentage points when AI was turned off — suggesting dependency, not genuine skill improvement. Without independent monitoring, you won't know if your team is building real skills or relying on AI as a crutch. ### The Solution: Independent AI Impact Measurement Scopia measures AI impact independently — no vendor bias, no guesswork. **AI-on vs. AI-off Comparison:** Compare ADR and other quality indicators with AI enabled versus disabled — per endoscopist. See the real uplift, not just vendor claims. **Per-Endoscopist Analytics:** Not every endoscopist benefits equally from CADe. Identify who gains the most and who may need additional training. **Vendor-Neutral:** Works with GI Genius, CAD EYE, ENDO-AID, and any other CADe system. Scopia doesn't sell AI — we measure if AI works. **Deskilling Detection:** Longitudinal tracking reveals whether endoscopists maintain their skills independently. Get early warnings when AI dependency develops. ### Who Benefits **For Hospitals:** Proof that your €100K+ investment is paying off. Evidence-based ROI reporting for hospital leadership and procurement reviews. **For AI Vendors:** Independent real-world evidence for regulatory submissions and sales materials. Third-party validation is more credible than internal data. **For Screening Programs:** Data-driven decisions on AI deployment. Understand which units benefit most and where training should be prioritised. ### The Only Independent AI Quality Measurement in Europe - No AI vendor can objectively measure their own impact - No EHR system tracks AI-on vs. AI-off quality - Scopia is vendor-neutral and designed for exactly this --- ## For Nurses URL: https://scopia.app/nurses ### Your 60 Seconds Make the Difference You already keep the endoscopy unit running. With Scopia, your quick quality logging directly improves patient outcomes — and you can see the impact. ### How It Works 1. **Open on any device:** Use the tablet, phone, or computer already in the endoscopy room. No app to install — just open the browser. 2. **Record in under 60 seconds:** Simple form with clear options. Record the key quality indicators during or right after the procedure. No coding required — just straightforward selections. 3. **Done — feedback is automatic:** That is it. Scopia automatically generates feedback for the endoscopist and updates the unit dashboard. Your part is done. ### What Nurses Say "It takes me about 45 seconds. I fill it in while the patient recovers. It doesn't add any real work to my day." — Endoscopy Nurse, Scopia Pilot Unit "I like that I can see the unit's quality improving over time. It feels like my contribution actually matters." — Endoscopy Nurse, Scopia Pilot Unit ### Scopia Champion Program Become the quality champion in your endoscopy unit. Lead the implementation and gain recognition for your contribution. - **Training:** Complete onboarding training and become the go-to person in your unit. - **Certificate:** Receive a Scopia Quality Champion certificate for your professional portfolio. - **Network:** Connect with quality champions from other units across Finland and Europe. - **Impact:** See the direct impact of your work on patient outcomes with real-time quality data. --- ## Security URL: https://scopia.app/security ### Built for Healthcare Security Requirements Scopia is designed so your IT department can say yes. Works out of the box without EHR integration — and offers optional integrations when you're ready. EU-hosted, no patient identifiers, and independently assessed by FinCCHTA. ### IT Procurement Checklist (All Met) - EU data residency (ISO 27001 certified) - No direct patient identifiers stored - No EHR integration required - No on-premise infrastructure needed - No VPN — HTTPS/TLS 1.3 only - Independently assessed (FinCCHTA Digi-HTA) - Not a medical device — standard SaaS procurement ### FinCCHTA Digi-HTA Assessment Valid: September 2025 — September 2028 Assessment Results: - Safety: Sufficient - Data Security & Protection: Sufficient - Costs: Reasonable - Usability & Accessibility: Sufficient - Long-term effectiveness: Ongoing research - Overall: Meets criteria mainly. All areas passed. ### Security Details **EU Data Residency:** All data stored and processed within the EU/EEA on ISO 27001 certified cloud infrastructure. No data leaves the European Economic Area. Encryption at rest and in transit. **GDPR Compliant:** Scopia stores no direct patient identifiers. Quality data is linked to endoscopists, not patients. Data Processing Agreement (DPA) available for all customers. **ISO 27005 Risk Management:** Risk management follows the ISO/IEC 27005 framework with quarterly reviews. Designated safety incident coordinator and documented risk management process. **Works Without — or With — Integration:** Start immediately as a standalone browser-based application. When ready, EHR and endoscopy system integrations are available. **Continuous Security Testing:** Regular vulnerability scanning, dependency monitoring, and cloud infrastructure security monitoring. Role-based access controls. Quarterly security reviews and automated alerts. **99.99% Uptime:** Built on EU-hosted cloud infrastructure with minimal downtime — six minutes total in the past six months. Automated daily backups. Automatic updates with zero disruption to clinical workflows. ### Not a Medical Device Scopia is a quality monitoring tool, not a medical device and not an AI system. This means significantly lower regulatory burden for your procurement process. - Not classified as a medical device under EU MDR - Not subject to EU AI Act requirements - No clinical decision support — purely quality monitoring - No patient-facing functionality - Standard SaaS procurement — no special approvals needed ### What Scopia Does NOT Do - Store direct patient identifiers - Make clinical decisions or recommendations - Use AI for diagnosis or detection - Require on-premise infrastructure ### Architecture Endoscopy Unit (browser-based, any device) → HTTPS/TLS 1.3 (no VPN required) → EU Cloud (EU/EEA region, ISO 27001 certified) - 0 required IT touchpoints - 0 on-premise components - No direct patient identifiers - Encrypted at rest and in transit - Daily automated backups ### Compliance Documents Available 1. Data Processing Agreement (DPA) 2. Security Fact Sheet 3. Privacy Impact Assessment 4. FinCCHTA Assessment Report 5. Security Testing Report 6. Infrastructure Hardening Guide 7. Risk Assessment Documentation --- ## About URL: https://scopia.app/about ### Built by Endoscopists, for Endoscopists We started Scopia because we saw a gap: the evidence on quality monitoring was clear, but most endoscopy units had no practical way to do it. "We built Scopia because we believed every endoscopy unit — not just the best-resourced ones — deserves access to quality monitoring." — Founding team, Espoo, Finland, 2023 ### Our Story Colonoscopy quality monitoring saves lives — the evidence is overwhelming. Yet in most hospitals, quality data is either not collected at all, or buried in spreadsheets that no one looks at. We built Scopia to change that. Starting with a pilot at South Savo Hospital District, we developed a system that makes quality monitoring effortless: nurses log data in 60 seconds, endoscopists get automatic feedback, and chief physicians see everything on one dashboard. The pilot led to a 20 percentage point increase in ADR and won the Finnish Medical Association Quality Award 2025. Today, we're expanding across Finland and into the Nordics, Austria, and Switzerland. ### Timeline - 2023: Company founded in Espoo - 2024: Pilot launched at South Savo Hospital District - 2025: Mehiläinen network rollout, Digi-HTA evaluation & Finnish Medical Association Quality Award - 2026: Nordic expansion ### What We Stand For **Patient Safety First:** Every feature we build starts with one question: does this improve patient outcomes? Quality monitoring exists to save lives — everything else is secondary. **Science-Driven:** Our approach is grounded in published research on colonoscopy quality, audit and feedback, and behavioural change. We build what the evidence supports. **Accessible to All:** Quality monitoring shouldn't require large IT budgets or complex integrations. We designed Scopia so that any endoscopy unit — public or private, large or small — can start in days. ### Partners & Recognition - Finnish Medical Association (Quality Award 2025) - FinnCHTA Digi-HTA (Assessment 2025-2028) - Mehiläinen (Network-wide rollout) - Health Incubator Helsinki ### Company Scopia Oy is a Finnish health technology company. We are a focused team with deep expertise in gastroenterology, healthcare IT, and quality improvement. Based in Espoo, Finland. --- ## Contact / Book a Demo URL: https://scopia.app/contact See how Scopia can raise colonoscopy quality in your endoscopy unit. 15-minute online demo, no commitment. ### What to Expect - 15-minute personalised demo tailored to your unit - See real dashboards and quality reports - Discuss your unit's specific needs - No commitment or credit card required ### Research Inquiries Tell us about your research question and we'll show you how Scopia can serve as your multi-center data collection infrastructure. Research License includes: - Full Scopia platform for all participating centers - Standardized, publication-ready data collection - Anonymized international benchmarking data - Up to 50% reduced academic pricing Contact: info@scopia.app — Helsinki, Finland --- ## Key Statistics - Every 1% ADR increase = 3% fewer interval cancers (Corley et al., NEJM 2014) - Audit and feedback improves ADR by average 7 percentage points - South Savo ADR: 53% (from 33% baseline, +20pp) - Mehiläinen: 15+ units, 50+ endoscopists, 1,000+ pilot colonoscopies - Quality logging: under 60 seconds per procedure - Setup time: under 1 week - Uptime: 99.99% - CADe deskilling risk: -6pp ADR when AI turned off (Lancet GH, 2025) - FinCCHTA Digi-HTA valid: September 2025 — September 2028 ## Clinical Evidence References - Corley DA et al. Adenoma Detection Rate and Risk of Colorectal Cancer and Death. New England Journal of Medicine, 2014. - ESGE Quality Performance Measures for Colonoscopy. European Society of Gastrointestinal Endoscopy. - Lancet Gastroenterology & Hepatology, 2025 — CADe deskilling study. - Finnish Medical Association Quality Award 2025 — South Savo Hospital District. ## Languages All content is available in: - English (default): https://scopia.app/ - Finnish: https://scopia.app/fi/ - Swedish: https://scopia.app/sv/ - German: https://scopia.app/de/